PITTSBURGH, May 13, 2011 (GLOBE NEWSWIRE) -- From research and development to manufacturing, pharmaceutical companies spend billions of dollars to bring new drug products to market and sustain the production of more established ones. In two upcoming webinars, experts at Gateway Analytical and Exemplar Pharma will present unique particle characterization and problem-solving methods that can drastically impact the time and costs associated with generic drug development and nonconformance investigations.
Solving Contamination Issues with Pharmaceutical Forensics
Timing: Tues., May 24, 2011, 1-2 p.m. ET
Presenter: David Exline, Senior Vice President, Gateway Analytical
Cost: Complimentary
Web: http://Ez.com/PFwebinar
For pharmaceutical manufacturing companies, the presence of foreign particulate matter and other contaminants can halt the production of drug products for weeks, even months, until the contaminant and the source are identified and the issue is fully resolved. This webinar will explore how a new advanced problem solving approach, pharmaceutical forensics, is used to quickly identify foreign particulate matter and answer questions as to how, where and when it originated.
Advancing Development of Generic OINDPs through In Vitro Testing
Timing: Weds., June 22, 2011, 1-2 p.m. ET
Presenters: Ryan Priore, Ph.D., Director of Applications & Contract Services, Gateway Analytical;
Charles Eck, President, Exemplar Pharma
Cost: Complimentary
Web: http://Ez.com/genericswebinar
According to a 2007 report by J.A. DiMasi, companies spend an estimated $1.3 billion on research and development for each approved drug due to the increasing complexity of the research and development process—particularly clinical trials. This webinar will demonstrate how novel ingredient-specific particle characterization methods, along with scientific and regulatory expertise, can help cut the time and costs associated with getting generic orally inhaled and nasal drug products (OINDP) to market.
Visit http://Ez.com/pharmawebinars for more information and to register.
Media Contact:
Suzanne Cibotti
Sr. Marketing Communications Specialist
Tel: 412.241.7335, ext. 291
cibottis@gatewayanalytical.com
Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries. Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
This information was brought to you by Cision http://www.cisionwire.com
http://www.cisionwire.com/gateway-analytical/r/pharmaceutical-webinars-to-tackle-major-issues-in-drug-development-and-manufacturing,g9122277